Novel monoclonal antibody can substantially lower triglycerides in patients with acute pancreatitis ...Middle East

- News
Novel monoclonal antibody can substantially lower triglycerides in patients with acute pancreatitis
The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai.

Hence then, the article about novel monoclonal antibody can substantially lower triglycerides in patients with acute pancreatitis was published today ( ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel monoclonal antibody can substantially lower triglycerides in patients with acute pancreatitis )

Apple Storegoogle play

Last updated :

Also on site :